UK markets closed

TerrAscend Corp. (TED.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.5400+0.0300 (+1.99%)
At close: 08:18AM CEST

TerrAscend Corp.

East Tower
Suite 501 77 City Centre Drive
Mississauga, ON L5B 1M5
Canada
717-610-4165
https://www.terrascend.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees944

Key executives

NameTitlePayExercisedYear born
Mr. Jason Garrett Wild R.Ph.Executive ChairmanN/AN/A1973
Mr. Ziad GhanemPresident & CEO826.68kN/A1978
Mr. Keith StaufferChief Financial Officer668.42kN/A1970
Ms. Lynn GefenChief Legal Officer & Corporate Secretary492.03kN/A1971
Mr. David WheelerSenior VP & Chief Information OfficerN/AN/AN/A
Mr. BJ CarrettaSenior Vice President of MarketingN/AN/AN/A
Mr. Jeroen De BeijerChief People & Culture OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Corporate governance

TerrAscend Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.